Recent headlines around the federal government’s move to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) have sparked optimism across the cannabis industry. For many operators, this shift feels like a long-awaited step toward normalization, legitimacy, and improved access to financial services.
However, one critical misconception continues to surface:
Rescheduling cannabis to Schedule III does not make credit card acceptance compliant for plant-touching cannabis businesses, but fret not, there are still options for non-cash alternatives available.
At Evolve Payment, we believe clarity matters, especially when compliance, banking relationships, and business continuity are on the line. Let’s break down what Schedule III really means, and why credit cards remain off the table for plant-touching cannabis operators.
Moving cannabis to Schedule III would represent a meaningful federal policy shift, including:
These are positive developments. However, rescheduling does not equate to federal legalization, nor does it automatically unlock access to traditional financial services.
Despite rescheduling, credit card networks and issuing banks are still governed by federal law, card network rules, and institutional risk frameworks that prohibit cannabis transactions.
Even under Schedule III, cannabis remains a federally controlled substance. Credit card networks are not willing to process transactions tied to the sale of a federally regulated drug outside of FDA-approved pharmaceutical channels.
Plant-touching cannabis products sold at dispensaries do not meet those criteria.
Visa, Mastercard, Discover, and American Express operate under strict network compliance requirements. Today, those rules:
Until the card networks formally update their rules, credit card acceptance remains a violation, regardless of rescheduling.
Banks and card issuers are regulated by federal agencies such as the FDIC, OCC, and Federal Reserve. These institutions must continually evaluate:
Schedule III does not eliminate these concerns for retail cannabis sales, particularly when products are not FDA-approved or distributed through traditional pharmaceutical channels.
Some operators may hear claims that rescheduling allows for “creative” or “quiet” credit card acceptance. In practice, these arrangements often involve:
These practices significantly increase the risk of sudden account shutdowns, frozen funds, and long-term banking harm, often without warning. We witness this with the recent Ella Cash “cashless ATM” shutdown that happened in early December of 2025; non-compliant solutions are still facing scrutiny.
Debit card transactions are governed by the same card network rules and banking oversight frameworks as credit cards. Even though funds originate from a consumer’s bank account, the transaction still clears through card networks such as Visa and Mastercard.
As of today:
Many so-called “debit solutions” rely on:
These approaches are not compliant, regardless of how they are marketed.
While no card-based solutions are compliant for plant-touching cannabis sales, operators typically rely on:
Each option carries operational considerations, and not all are appropriate for every operator or market. The key differentiator is whether the solution is fully disclosed, bank-approved, and designed specifically for cannabis, rather than adapted from traditional retail payments.
Below are primary regulatory and policy sources that govern cannabis payments today.
Federal Law
Financial Crime & Banking Guidance
Card Network Rules
Note: Card network rules are binding on acquiring banks and processors—not just merchants.
Until then, card-based payments remain prohibited.
Rescheduling cannabis to Schedule III is meaningful, but it does not change the compliance reality for payments.
Credit cards and debit cards remain non-compliant for plant-touching cannabis businesses. Operators should be cautious of any provider suggesting otherwise.
At Evolve Payment, we focus on transparent, regulator-aligned solutions that protect operators, banks, and the long-term viability of the cannabis industry. Reach out today to learn about our compliant solution that allows for direct bank-to-bank transfers to happen easily for your customers.
The future of cannabis payments is compliant: not covert.